media

Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
Glenmark Life Sciences Ltd.
( in Crs.)

ParticularsMar 24Mar 23Mar 22Mar 21Mar 20
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)PRARARARAR
FaceValue2.002.002.002.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax631.29628.61564.93470.94421.07
      
Net CashFlow From Operating Activities413.52313.40597.59388.11195.01
Net Cash Used In Investing Activities-116.48-154.15-122.23-68.73-50.52
Net Cash Used From Financing Activities-279.44-387.59-78.80-213.78-136.55
      
Net Inc/Dec In Cash And Cash Equivalents17.59-228.33396.56105.607.94
Cash And Cash Equivalents Begin of Year283.82512.16115.6010.002.06
Cash And Cash Equivalents End Of Year301.41283.82512.16115.6010.00
ParticularsMar 24
Months12
Source Of Info (AR = Annual Report, PR = Press Release)PR
FaceValue2.00
  
Net Profit/Loss Before Extraordinary Items And Tax631.29
Net CashFlow From Operating Activities413.52
Net Cash Used In Investing Activities-116.48
Net Cash Used From Financing Activities-279.44
Net Inc/Dec In Cash And Cash Equivalents17.59
Cash And Cash Equivalents Begin of Year283.82
Cash And Cash Equivalents End Of Year301.41